Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-17-145438
Filing Date
2017-04-28
Accepted
2017-04-28 08:30:03
Documents
3
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A d384663d10ka.htm 10-K/A 352594
2 EX-31.3 d384663dex313.htm EX-31.3 2267
3 EX-31.4 d384663dex314.htm EX-31.4 2262
  Complete submission text file 0001193125-17-145438.txt   358279
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-31791 | Film No.: 17791773
SIC: 2834 Pharmaceutical Preparations